Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1601 to 1625 of 1781 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
2068 Increase, Endothelial Dysfunction
0 Tissue Sep 28, 2022 Mar 21, 2023 470: Deposition of energy leads to vascular remodeling
2069 Occurrence, Vascular Remodeling
1 Organ Oct 17, 2022 Mar 21, 2023 470: Deposition of energy leads to vascular remodeling
2070 Increase, Glycolysis
0 Cellular Nov 1, 2022 Nov 1, 2022 267: Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion
2071 Decrease, Glucose pool
0 Cellular Nov 1, 2022 Nov 1, 2022 267: Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion
2072 Increase, Mitochondrial swelling
0 Cellular Nov 1, 2022 Nov 1, 2022 268: Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling
2073 increase oxidation of the di-copper moiety of the hemocyanin active site
0 Molecular Nov 16, 2022 Nov 16, 2022 473: Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
2074 Decreased, oxygen binding capacity by hemocyanin
0 Molecular Nov 16, 2022 Nov 16, 2022 473: Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
2075 Cognitive, sensed as hypoxic/low oxygen environment
0 Organ Nov 16, 2022 Nov 16, 2022 473: Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
2076 Increase, hemocyanin mRNA
0 Tissue Nov 16, 2022 Nov 16, 2022 473: Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
2077 Increase, pulmonate breathing
0 Individual Nov 16, 2022 Nov 16, 2022 473: Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
2078 Loss of drebrin
0 Cellular Dec 11, 2022 Dec 11, 2022
2079 Increased, glycolipid levels
0 Cellular Dec 13, 2022 May 17, 2023 476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
2080 Impaired, blood testis barrier
0 Organ Dec 13, 2022 Dec 13, 2022 476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
2081 Increased Modified Proteins
0 Molecular Dec 16, 2022 Mar 8, 2024 478: Deposition of energy leading to occurrence of cataracts
2082 Hypospadias, increased
1 Organ Dec 18, 2022 Apr 16, 2024
2083 Occurrence of Cataracts
1 Organ Dec 18, 2022 Mar 8, 2024 478: Deposition of energy leading to occurrence of cataracts
2084 Increase, Cardiac remodelling
0 Tissue Jan 5, 2023 Jan 5, 2023 479: Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress
2085 Pulmonary epithelial injury
0 Cellular Jan 9, 2023 Jul 11, 2023 481: AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
2086 Airway inflammation
0 Organ Jan 9, 2023 Jan 17, 2023 481: AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
2087 Increased incidence of respiratory disease
0 Individual Jan 9, 2023 Jan 9, 2023 481: AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
2088 Dysfunction of respiratory system
0 Individual Jan 9, 2023 Jan 9, 2023 481: AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
2089 Altered Bone Cell Homeostasis
0 Cellular Jan 11, 2023 Mar 22, 2023 482: Deposition of energy leading to occurrence of bone loss
2090 Increase, Bone Remodeling
0 Tissue Jan 11, 2023 Mar 22, 2023 482: Deposition of energy leading to occurrence of bone loss
2091 Occurrence, Bone Loss
0 Organ Jan 11, 2023 Mar 22, 2023 482: Deposition of energy leading to occurrence of bone loss
2092 Promotion, Ovarian Cancer
1 Organ Jan 12, 2023 Mar 11, 2023 440: Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia